A Walgens vaccine schedule has been canceled, which means Walgarts US vaccine rate has fallen below 1%, according to a new report from Bloomberg.
The decline is likely due to a decline in the number of people who have been vaccinated.
The company’s vaccine schedule was expected to have a vaccine rate of over 4%, Bloomberg reported, citing data from the US Centers for Disease Control and Prevention.
Bloomberg noted that Walgards vaccine rate fell to 3.8% in December.
The drop in vaccine rate is a huge loss for the company.
“We don’t have a lot of people to vaccinate and a lot more people are dying in this country from other diseases, which is a real issue,” Walgills chief medical officer, Brian Wiederman, said.
The report comes amid the Trump administration’s push to roll back a number of vaccination programs in the US, including a $25 billion block grant to states and an expansion of Medicaid to cover children up to age 25.
A similar push to defund a number other vaccines has also been put forward by the White House, as well as by the governors of California, Maryland, New York, Pennsylvania and Washington.
“It’s not just about the vaccine, it’s about the quality of vaccines,” Dr. David M. Dettmer, director of the Johns Hopkins Bloomberg School of Public Health, told Bloomberg.
“And we are losing people because we are not putting enough resources in.”
Walgreen announced in February that it had reached an agreement with the CDC to allow the company to stop distributing its vaccine schedule.
However, it did not offer an exact timeline for when the vaccine schedule will be available.
The plan, which was originally slated to be released this fall, was reportedly scrapped due to “significant uncertainty.”
The CDC, in a statement to Business Insider, said that Walgreen will be able to continue distributing its vaccines once the “significant uncertainties” are resolved.